Ibrutinib 140Mg Capsules
Price range: $700.00 through $1,200.00
| Quantity Value | Price | Price/Unit | Quantity | Add To Cart |
|---|---|---|---|---|
| 100 Capsules | $700.00 | $7.00 / Piece |
|
|
| 200 Capsules | $1,200.00 | $6.00 / Piece |
|
SKU : N/A
Category : Other
Ibrutinib 140 mg Capsules
Ibrutinib 140 mg Capsules contain ibrutinib, a prescription medicine belonging to a group of medicines called Bruton’s tyrosine kinase (BTK) inhibitors. It is an oral targeted therapy used in the treatment of certain blood cancers and disorders involving abnormal B-cell activity. Ibrutinib works by interfering with signaling pathways that help certain abnormal B cells survive, grow, and spread.
Ibrutinib is used under the supervision of a qualified oncologist or hematologist. The appropriate dose and treatment schedule depend on the specific disease being treated, the patient’s overall health, other medicines being taken, and the response to treatment.
Uses of Ibrutinib 140 mg
Ibrutinib may be prescribed for certain types of B-cell malignancies, including specific forms of leukemia and lymphoma. Depending on the approved indication in a particular country, it may be used in conditions such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia, and certain other B-cell cancers.
It may be used alone or in combination with other anticancer medicines. The exact treatment regimen is determined by the treating specialist based on the patient’s diagnosis and current clinical guidelines.
Because cancer treatment varies considerably between individuals, Ibrutinib should only be used for the condition for which it has been prescribed.
How Ibrutinib Works
Ibrutinib is a Bruton’s tyrosine kinase inhibitor. BTK is an important protein involved in signaling within B cells. These signals help B cells communicate, survive, multiply, and migrate.
By inhibiting BTK, ibrutinib disrupts these signaling pathways. This can reduce the survival and proliferation of abnormal B cells and may slow the progression of certain B-cell cancers.
As a targeted therapy, ibrutinib acts on a specific biological pathway rather than affecting all rapidly dividing cells in the same way as many traditional chemotherapy medicines.
How to Take Ibrutinib 140 mg Capsules
Ibrutinib should be taken exactly as prescribed by an oncologist or other qualified healthcare professional. The number of capsules required each day depends on the specific indication and treatment regimen.
Capsules should generally be swallowed whole with water. They should not be opened, crushed, or chewed unless specifically instructed by a healthcare professional.
Patients should try to take the medicine at approximately the same time each day. If a dose is missed, the patient should follow the instructions provided by the treating team and should not take an extra dose unless specifically advised.
Common Side Effects
Ibrutinib can cause side effects, although not everyone experiences them. Commonly reported effects may include diarrhea, tiredness, nausea, muscle or joint pain, bruising, rash, and upper respiratory symptoms.
Changes in blood counts can also occur, including reduced levels of certain blood cells. Because of this, doctors may perform regular blood tests during treatment.
Patients should report persistent or severe side effects to their healthcare team. The doctor may adjust the dose, temporarily interrupt treatment, or provide supportive treatment when necessary.
Important Safety Information
One of the important risks associated with ibrutinib is bleeding. Patients may bruise more easily or experience nosebleeds or other bleeding. Serious bleeding can occur in some cases. Patients should promptly report unusual or heavy bleeding, blood in the urine or stool, vomiting blood, severe headache, or other concerning symptoms.
Ibrutinib may also increase the risk of infections because of its effects on the immune system. Fever, chills, persistent cough, or other signs of infection should be reported promptly.
Another potential complication is an abnormal heart rhythm, including atrial fibrillation or atrial flutter. Patients who develop palpitations, irregular heartbeat, chest discomfort, dizziness, or shortness of breath should seek medical evaluation.
Drug Interactions
Ibrutinib can interact with many medicines. Certain medicines may increase or decrease the amount of ibrutinib in the bloodstream and can therefore affect its safety or effectiveness.
Medicines that increase bleeding risk, including certain anticoagulants and antiplatelet medicines, may require special consideration. Patients should tell their doctor about all prescription medicines, over-the-counter products, vitamins, and herbal supplements they use before starting treatment.
Patients should also avoid starting or stopping medicines without discussing the change with their healthcare team.
Monitoring During Treatment
Regular medical monitoring is an important part of treatment with ibrutinib. Doctors may monitor blood counts, liver function, signs of infection, bleeding symptoms, heart rhythm, and overall response to therapy.
The treatment may be modified depending on laboratory results, side effects, other medical conditions, or changes in the patient’s cancer.
Pregnancy and Contraception
Ibrutinib may cause harm to an unborn baby. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss treatment with their healthcare professional before taking this medicine.
Appropriate contraception may be recommended during treatment and for a period after treatment, depending on medical advice and the applicable product information.
Storage
Ibrutinib capsules should be stored according to the manufacturer’s instructions, generally in a dry place at the recommended room temperature. Keep the medicine in its original packaging and out of the reach of children. Do not use capsules after their expiry date.
Conclusion
Ibrutinib 140 mg Capsules contain ibrutinib, a targeted BTK inhibitor used to treat certain B-cell cancers and related disorders. By blocking BTK signaling, the medicine can interfere with the growth and survival of abnormal B cells.
Because ibrutinib can cause significant adverse effects, including bleeding, infections, blood-count abnormalities, and heart rhythm problems, treatment requires careful medical supervision. Regular follow-up and laboratory monitoring are important for maintaining safety and assessing treatment response.
Patients should take Ibrutinib exactly as prescribed and should inform their healthcare team about all other medicines and supplements they use. Any unusual bleeding, signs of serious infection, irregular heartbeat, severe weakness, or other concerning symptoms should be reported promptly to a healthcare professional.
| Pack Size |
100 Capsules ,200 Capsules |
|---|
